XTL BIOPHARMACEUTICALS LTD

Watch

Share

XTLB·98386D406·US·ADR

XTLB (XTL BIOPHARMACEUTICALS LTD) is held by 2 institutional investors as of Q2 2026. Largest holders: RHUMBLINE ADVISERS ($17,000), UBS Group AG ($341). Net institutional sentiment: Mixed.

2

Holders

$17,341

Total Value

67% (3)

Consensus

2 buying - 1 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)37

Insider (Form 4)44

Activist (13D/13G)51

Congressional (STOCK Act)66

Holder Quality

39

★★★★★

Elite

55

★★★★

Strong

47

★★★

Solid

85

★★

Below

40

★

Weak

Held by 2 funds

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for XTLB.

Top Holders

Top Holders (2)History

AllNewIncreasedHeldDecreasedExited

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
RHUMBLINE ADVISERS	Increased	6,228(+4.0%)	$17,000	0.0%	+205.04%	13
UBS Group AG	New	125	$341	0.0%	-5.49%	17
MORGAN STANLEY	Exited	0(-100.0%)	$24	0.0%	+12.35%	0

XTLBXTL BIOPHARMACEUTICALS LTD

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer